Odonate Therapeutics, Inc.
ODTDelisted Jan 25, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001717452
Odonate Therapeutics, Inc. was delisted on Jan 25, 2022; its insiders filed their last Form 4 on Dec 10, 2021; 50 institutions reported holding it in 13F filings for Q4 2021, worth $32.7M in total; no superinvestor held it.
Holders of 5% or more of ODT
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Odonate Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Odonate Therapeutics, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
14 Schedule 13D and 13G filings on Odonate Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 14, 2022 | Ikarian Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2022 | Janus Henderson Group PLC | 13G/AOld format | – | – | – | SEC |
| Jan 28, 2022 | BML Investment Partners, L.P. | 13G/AOld format | – | – | – | SEC |
| Jan 28, 2022 | BML Investment Partners, L.P. | 13GOld format | – | New | – | SEC |
| Dec 10, 2021 | EcoR1 Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Nov 26, 2021 | Boxer Capital, LLC | 13D/AOld format | – | – | – | SEC |
| Nov 22, 2021 | Boxer Capital, LLC | 13D/AOld format | – | – | – | SEC |
| Nov 19, 2021 | Tang Capital Partners LP | 13D/AOld format | – | – | – | SEC |
| Nov 18, 2021 | EcoR1 Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Jul 19, 2021 | EcoR1 Capital, LLC | 13GOld format | – | New | – | SEC |
| Jul 2, 2021 | Ikarian Capital, LLC | 13GOld format | – | New | – | SEC |
| Apr 12, 2021 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | Janus Henderson Group PLC | 13GOld format | – | New | – | SEC |
| Feb 4, 2021 | Wellington Management Group LLP | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Odonate Therapeutics, Inc. shares.
No Form 144 notices for Odonate Therapeutics, Inc. are on file.